 On Tuesday, three public companies in the psychedelicsbiotech space announced significant milestones in their drug development pipelines. Field Trip Receives Notice Of Patent Allowance For Proprietary Psychedelic Molecule Field Trip Health NASDAQ:FTRP received a notice of allowance for a US patent application covering FT-104, its flagship psychedelic drug candidate. 